{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF00788",
      "entity_text" : "RA",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:59174488",
      "entity_text" : "spebrutinib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Unlike the clinical findings, spebrutinib treatment led to statistically significant changes versus placebo across several biomarkers of anti-inflammatory activity, confirming its mechanism of action and potential therapeutic biologic effects in RA.",
  "reading_complete" : "2020-07-28T16:59:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T16:55:57Z",
  "trigger" : "led",
  "evidence" : [ "spebrutinib treatment led to statistically significant changes versus placebo across several biomarkers of anti-inflammatory activity, confirming its mechanism of action and potential therapeutic biologic effects in RA" ],
  "pmc_id" : "7021855",
  "score" : 0
}